Product
Endostatin
1 clinical trial
2 indications
Indication
Advanced Solid TumorIndication
Refractory TumorClinical trial
A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor (Endo) in Combination With Bragg Treatment for Advanced Refractory Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2024-12-30